Low-dose VSV-EBOV vaccination provides rapid protection from lethal Ebola virus challenge
Andrea Marzi, Wakako Furuyama, Amanda J. Griffin, Friederike Feldmann, Kyle Shifflett, Elizabeth R. Wrobel, Kyle Lee O’Donnell, Patrick W. Hanley, Heinz Feldmann
This study evaluates the protective efficacy of low-dose VSV-EBOV vaccines in nonhuman primates, finding reduced protection with a Makona GP vaccine compared to a Kikwit GP vaccine.
bioRxiv · Feb 15, 2026 · PreprintMicrobiology